Definium Therapeutics issues inducement stock options for 334,810 shares to new hires
DFTX•Definium Therapeutics granted options covering 334,810 shares to 15 newly hired non-executive employees, with grants effective Sept. 28, 2026.
1. Option grant details
The options were issued under the company’s 2026 Inducement Plan, with exercise prices set at the closing share price on the effective date. They vest over four years: 25% after one year and the remaining 75% in substantially equal monthly installments over the following three years.
